DrugPatentWatch Database Preview
Patent: 9,499,616
» See Plans and Pricing
Summary for Patent: 9,499,616
Title: | Modulated lysine variant species compositions and methods for producing and using the same |
Abstract: | The instant invention relates to modulated lysine variant species compositions comprising a protein, e.g., an antibody, or antigen-binding portion thereof, and methods, e.g., cell culture and/or protein purification methods, for producing such modulated lysine variant species compositions. Methods for using such compositions to treat a disorder, e.g., a disorder in which TNF.alpha. is detrimental, are also provided. |
Inventor(s): | Subramanian; Kartik (Northborough, MA), Thiele; Mayda Perez (Vega Alta, PR), Zeng; Xiaobei (Carolina, PR), Wong; Chee Furng (Singapore, SG), Kaymakcalan; Zehra (Westborough, MA), Jing; Ying (Wellesley, MA), Chumsae; Christopher M. (North Andover, MA) |
Assignee: | ABBVIE INC. (Chicago, IL) |
Application Number: | 14/923,966 |
Patent Claims: | see list of patent claims |
Details for Patent 9,499,616
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie Inc | HUMIRA | adalimumab | VIAL | 125057 | 002 | 2002-12-31 | Start Trial | ABBVIE INC. (Chicago, IL) | 2033-10-18 | RX | Orphan | search |
Abbvie Inc | HUMIRA | adalimumab | SYRINGE | 125057 | 001 | 2002-12-31 | Start Trial | ABBVIE INC. (Chicago, IL) | 2033-10-18 | RX | Orphan | search |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 9,499,616
Country | Patent Number | Estimated Expiration |
---|---|---|
United States of America | 2015110775 | Start Trial |
United States of America | 2016237150 | Start Trial |
United States of America | 2017121403 | Start Trial |
United States of America | 9181337 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |